Drug Interactions of Tipranavir, a New HIV Protease Inhibitor

By  

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 81-84

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Interactions between HIV Protease Inhibitors and Acid-Reducing Agents

By Falcon Ronald W.  

Clinical Pharmacokinetics, Vol. 47, Iss. 2, 2008-01 ,pp. : 75-89

Adis International

Access to resources Recommend Favorite

Drug Interactions of HIV Protease Inhibitors

By Malaty L.I.  

Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. : 147-169

Adis International

Access to resources Recommend Favorite

Interactions between new quinolone antibacterials and diagnostic drug containing manganese

By Hosono Moeko   Yokoyama Haruko   Takayanagi Risa   Yamada Yasuhiko  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 255-259

Springer Publishing Company

Access to resources Recommend Favorite

Potential role of intestinal first-pass metabolism in the prediction of drug–drug interactions

By Galetin Aleksandra   Gertz Michael   Houston J Brian  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 909-922

Informa Healthcare

Access to resources Recommend Favorite